During the past decade, Az. Osp. Uni Ria Policlinico Tor Vergata; Unita Di Ematologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Az. Osp. Uni Ria Policlinico Tor Vergata; Unita Di Ematologia" are "Diffuse Large B-Cell Lymphoma" (1 trials), "Leukemia, Myeloid, Acute" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Az. Osp. Uni Ria Policlinico Tor Vergata; Unita Di Ematologia" in a lesser frequency.

Most popular intervention types in "Az. Osp. Uni Ria Policlinico Tor Vergata; Unita Di Ematologia" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (1 trials), "Gemcitabine" (1 trials), "Idasanutlin" (1 trials), "Oxaliplatin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Az. Osp. Uni Ria Policlinico Tor Vergata; Unita Di Ematologia" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Az. Osp. Uni Ria Policlinico Tor Vergata; Unita Di Ematologia". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Az. Osp. Uni Ria Policlinico Tor Vergata; Unita Di Ematologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Az. Osp. Uni Ria Policlinico Tor Vergata; Unita Di Ematologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".